Evidence map›Paper›PMID 40995802›Full record

Observational studyJournal of comparative effectiveness research2025

Comparative safety and effectiveness of direct oral anticoagulants and warfarin in patients with venous thromboembolism in Finland, Norway and Sweden.

Waleed Ghanima, Hanna Pohjantähti, Dimitra Lambrelli, Beth Nordstrom, Alison Booth, Sophie Graham, Ruth Mokgokong, Aaron Jenkins, Jose Chaves, Feng Dai and 2 more

Abstract readComparative StudyMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of comparative effectiveness research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Waleed GhanimaInternal Medicine Clinic & Department of Research, Østfold Hospital, Norway.ORCID 0000-0003-2225-6165
Hanna PohjantähtiTampere University Hospital, Heart Center, Tampere, Finland.
Dimitra LambrelliEvidera Ltd, London, UK.
Beth NordstromEvidera Ltd, London, UK.
Alison BoothEvidera Ltd, London, UK.
Sophie GrahamEvidera Ltd, London, UK.ORCID 0000-0002-7770-1863
Ruth MokgokongPfizer Ltd., Walton Oaks, Surrey, UK.ORCID 0000-0002-6278-4969
Aaron JenkinsPfizer Ltd., Walton Oaks, Surrey, UK.ORCID 0000-0001-9785-9388
Jose ChavesPfizer SLU., Madrid, Spain.
Feng DaiPfizer Inc., Groton, New York, USA.ORCID 0000-0002-9963-6863
Rupesh SubashEvidera Ltd, London, UK.
Anders GottsäterLund University, Department of Clinical Sciences in Malmö, Malmö, Sweden.ORCID 0000-0003-0865-0000

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticoagulantsFactor Xa InhibitorsPyridonesRivaroxabanVenous ThromboembolismWarfarinAdministration, OralAdultAgedFemaleFinlandHemorrhageHumansMaleMiddle AgedNorwayAnticoagulantsapixabanFactor Xa InhibitorsPyrazolesPyridonesRivaroxabanWarfarinanticoagulant agentseffectivenesssafetyvenous thromboembolism

Identifiers

PMID40995802
PMCPMC12580917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.